Previous 10 | Next 10 |
SESN is a clinical-stage biopharma company working on the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). FDA declined to approve the company's flagship drug Vicineum. Subsequently, management has started a strategic review. SESN trades ...
Sesen Bio press release (NASDAQ:SESN): Q1 GAAP EPS of -$0.07 beats by $0.03. Balance sheet of $170 million in cash and cash equivalents as of March 31, 2022, expected to fund current operating plan into the fourth quarter of 2024 For further details see: Sesen Bio GAAP EPS of -$0.07 bea...
Strong balance sheet of $170 million in cash and cash equivalents as of March 31, 2022, expected to fund current operating plan into the fourth quarter of 2024 Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeutic...
Why These 3 Penny Stocks Climbed on May 5th Finding penny stocks to buy in 2022 can be challenging. But, you need to be willing to put in the hard work and due diligence. Despite what you may think, it is possible to find penny stocks that will be profitable. However, it all comes d...
Penny stocks are generally shares of companies trading for less than $5 per share. While newer traders might consider most to be OTC (over-the-counter) stocks only, there are hundreds of issuers traded on significant exchanges. NYSE and NASDAQ penny stocks have grown in popularity t...
The shares of Sesen Bio (NASDAQ:SESN) have added ~24% in the pre-market Tuesday after the clinical-stage biotech disclosed it started a review of strategic alternatives that will include a sale of the company. “Our strong cash position provides us the opportunity to carefully...
Sesen Bio (Nasdaq: SESN ), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that it has initiated a process to review strategic alternatives with the goal of maximizing shareholder value. Pot...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back to another busy day of trading as we break down the biggest pre-market stock movers for Monday! Source: f11photo/Shutterstock.com Moving stocks this morning are a buyout deal, a 5G agreement, and more. ...
You can make money with penny stocks if you know how to trade. Sure, some might get lucky here and there, catching a big breakout. However, in general, even when you’re looking at stocks under $1, you can consistently profit. You just need to know how to handle volatility and risk. I...
Clinical-stage biotech, Sesen Bio (NASDAQ:SESN), is trading higher in the pre-market Thursday after the company updated on its resubmission plans for Vicineum, an investigational therapy for non-muscle invasive bladder cancer. Last year, U.S. Food and Drug Administration (FDA) declined to app...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...